Jul. 23 at 7:37 PM
$ALZN Looks like Alzn will skirt past the new Nasdaq delisting requirement for now, At least
$5M marketcap or immediate suspension after 30 days. With 4.8 M shares at 1.30, that's
$6.2M. They have until 9-16, unless granted an another extension, to get shareholder equity up. That's means they would have to partner with another biotech, which I don't see happening now, do a share deal with a private investor, or get share price up and sell more shares. They need at least
$5M to see the BP trial thru results. Last year the stock jumped 75% when the first patient was dosed in the lithium brain study. If history repeats, that would help get to trials results.
